Critical review of acylation-stimulating protein physiology in humans and rodents (Q35051385)

6 August 2017

1 reference

title

Critical review of acylation-stimulating protein physiology in humans and rodents (English)

1 reference

6 August 2017

0 references

1

Katherine Cianflone

1 reference

6 August 2017

Zhunan Xia

2

1 reference

6 August 2017

Lan Ying Chen

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

number of pages

17

1 reference

Biochimica et Biophysica Acta

inferred from page(s)

published in

1 reference

6 August 2017

volume

1609

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

127-143

1 reference

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Differentiation-induced production of ASP in human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Crystal structure analysis and molecular model of human C3a anaphylatoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

1H NMR studies of human C3a anaphylatoxin in solution: sequential resonance assignments, secondary structure, and global fold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Molecular cloning and characterization of the human anaphylatoxin C3a receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Human acylation-stimulating protein and lipid biosynthesis in bovine adipose tissue explants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Purification and characterization of acylation stimulating protein from porcine serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Human acylation stimulating protein enhances triacylglycerol biosynthesis in plant microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

ASP stimulates glucose transport in cultured human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Human C′3: Evidence for the Liver as the Primary Site of Synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Synthesis of factor D by normal human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Biosynthesis of complement protein D by HepG2 cells: a comparison of D produced by HepG2 cells, U937 cells and blood monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Regulation of alternative pathway activation and C3a production by adipose cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Differentiation dependent biphasic regulation of adipsin gene expression by insulin and insulin-like growth factor-1 in 3T3-F442A adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Effect of body weight and caloric restriction on serum complement proteins, including Factor D/adipsin: studies in anorexia nervosa and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Association of serum C3 levels with the risk of myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Serum complement and familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Correlations between serum lipids and complement components in adults without demonstrated atherosclerotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The effects on complement component 3 of dietary variation of protein, fat and vitamin E during growth of young mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Differential modulation of complement factor H and C3 expression by TNF-alpha in the rat. In vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Increased expression of complement component C3 in the plasma of obese Zucker fa and LA/N fa(f) rats compared with their lean counterparts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Adipsin and complement factor D activity: an immune-related defect in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Regulation of adipsin and body composition in the monosodium glutamate (MSG)-treated mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Adipsin mRNA amounts are not decreased in the genetically obese Zucker rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Severely impaired adipsin expression in genetic and acquired obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Reduced adipsin expression in murine obesity: effect of age and treatment with the sympathomimetic-thermogenic drug mixture ephedrine and caffeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Complement C3 deficiency: human, animal, and experimental models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Complement and complement deficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Phenotypes of complement knockouts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Abrogation of the alternative complement pathway by targeted deletion of murine factor B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Complement activation in factor D-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Viewpoint: are studies in genetically altered mice out of control?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Atherosclerosis and plasma and liver lipids in nine inbred strains of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Diet-induced type II diabetes in C57BL/6J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Increased insulin mediated glucose metabolism in fat cells from I versus C57BL mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Reinforcing and neurochemical effects of cocaine: differences among C57, DBA, and 129 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Genetic evidence that cocaine and caffeine stimulate locomotion in mice via different mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Development and genetics of glutamate taste preference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Strain dependent rate of Li+ elimination associated with toxic effects of lethal doses of lithium chloride in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Electrophysiological characterisation of the dentate gyrus in five inbred strains of mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Strain differences in consumption of saline solutions by mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Regional metabolic disturbances and cerebrovascular anatomy after permanent middle cerebral artery occlusion in C57black/6 and SV129 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Mapping a gene for combined hyperlipidaemia in a mutant mouse strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Complement activation after prolonged exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Protein metabolism in obese patients during very low-calorie mixed diets containing different amounts of proteins and carbohydrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Nitrogen economy during very low calorie reducing diets: quality and quantity of dietary protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

7 January 2021

inferred from DOI database lookup

The Complement Abnormalities of Lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Disorders of the complement system in lipodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Complement-mediated adipocyte lysis by nephritic factor sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Role of the sulfonylurea receptor in regulating human adipocyte metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Genome-wide linkage analysis of systolic and diastolic blood pressure: the Québec Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Insulin resistance in obesity: metabolic mechanisms and measurement methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Glucose-fatty acid interactions in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The adipocyte, fatty acid trapping, and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The regulators of complement activation (RCA) gene cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Functional consequences of the genetic polymorphism of the third component of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Molecular basis of polymorphisms of human complement component C3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Different allotypes of C3 degrade at different rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Mouse strains with typical mammalian levels of complement activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

C3 polymorphism in patients with chronic uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Studies of the C3 polymorphism. Relationship between phenotype and conversion rate in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Studies on the C3 polymorphism. Relationship between phenotype and quantitative immunochemical measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Association between coronary heart disease and the C3F-gene in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Association between the C3F gene and atherosclerotic vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

C3 polymorphism in a group of old arteriosclerotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Molecular analysis of C3 allotypes in patients with nephritic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Partial lipodystrophy and familial C3 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The effect of ASP on the adipocyte of the morbidly obese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Modulation of chylomicron remnant metabolism by an hepatic hydroxymethylglutaryl coenzyme A reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Congenital leptin deficiency is associated with severe early-onset obesity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Behavioral and biological determinants of leptin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Cytokines, leptin, and the hypothalamo-pituitary-adrenal axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Immunocompetence in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Complements in diabetes mellitus: activation of complement system evidenced by C3d elevation in IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

Lipoprotein lipase and the disposition of dietary fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2802%2900686-7

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0005-2736(02)00686-7

1 reference

release_53vaxali4bdc7mdjgo7gfhic34

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/53vaxali4bdc7mdjgo7gfhic34

24 November 2022

mapped directly with Wikidata item

1 reference